New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
OrphoMed Passes First Interim Analysis in Phase 2 Study of Treatment for IBS-D Patients
-
Beyond Identity Makes Passwordless Free
-
Beyond Identity Makes Passwordless Free
-
400+ Investors, Innovators and Strategics Confirmed For LSI 2021 Emerging Medtech Summit in Southern California
-
Hennessy Capital Investment Corp. V Announces the Appointment of Independent Directors and the Formation of a Strategic Advisory Council
-
Hennessy Capital Investment Corp. V Announces the Appointment of Independent Directors and the Formation of a Strategic Advisory Council
-
Fugue Announces Container Runtime Security Capabilities for Amazon Web Services and Microsoft Azure
-
Théa Chooses OmniSci to Capture, Analyze and Visualize Automotive Data at Scale to Drive Connected Vehicle and Telematics Innovation
-
CIT’s Virginia Founders Fund Invests in Industrial Intelligence to Advance the Hazardous Dust Monitoring Market
-
Topia Closes Out 2020 With Solid Growth, Pushing Ahead with Innovation in 2021 to Help Companies Navigate Post-Pandemic Business Challenges
-
Blu Digital Group Closes Multi-Million Dollar Series A Investment Round from Leading Silicon Valley Investor
-
CIT GAP Funds 2020 Impact Report Showcases $32.4 Million in Capital Deployed to Date
-
Everactive Raises Oversubscribed $35 Million Series C Financing to Accelerate Growth of Batteryless Pervasive Remote Monitoring for Industry 4.0
-
OmniSci Wins 2021 BIG Innovation Award
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Korro Bio to Present at J.P. Morgan Healthcare Conference
-
New Wave Foods® Completes $18 Million Series A Financing as it Focuses on Delivering Plant-Based Shrimp and Sustainable Shellfish Options to Market
-
Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-Generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform
-
Strive Health Names Rich Whitney to its Board of Directors
-
Qpex Biopharma Strengthens Leadership Team and Provides Update on BARDA Award for Portfolio of Drugs for Antimicrobial Resistance (AMR)
-
MBX Biosciences Appoints Mary Jane Geiger, M.D., Ph.D., as Chief Medical Officer
-
Form SC 13D Desktop Metal, Inc. Filed by: New Enterprise Associates 15, L.P.
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Closes $100M Underwritten Public Offering
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
Desktop Metal Announces Appointment of Scott Dussault as New Director Following Recent Election of Stephen Nigro
-
Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
-
Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
-
First RCT-DUPLICATE Findings Published in Circulation
-
Arris Wins Bosch Venture Arm to Bring Advanced Composites to New Sectors
-
Strive Health Appoints Dr. Kavita Patel to its Board of Directors
-
Ivantis Recognized For Innovation, Excellence And Company Culture
-
Bestow Announces $70 Million in Series C Funding
-
StreamSets Expands Native Cloud Solutions For Modern Data Integration
-
Independence Blue Cross and Strive Health Launch New Kidney Disease Care Management Program
-
Form SC 13D/A Mersana Therapeutics, Filed by: New Enterprise Associates 14, L.P.
-
OmniSci Recognized as the Best Data Visualization Solution by the 2020 Tech Ascension Awards
-
Reneo Pharmaceuticals Raises $95 Million in Series B Financing, Co-led by Novo Ventures and Abingworth
-
Beyond Identity Raises $75 Million to Take Customers Beyond Passwordless to the Identity Platform of the Future
-
Beyond Identity Raises $75 Million to Take Customers Beyond Passwordless to the Identity Platform of the Future
-
Form 4 Regulus Therapeutics For: Dec 04 Filed by: New Enterprise Associates 16, L.P.
-
Fugue Appoints Josh Stella as CEO and David Mitchell as President and COO
-
FiscalNote Secures $160 Million in Financing and Growth Capital
-
FiscalNote Secures $160 Million in Financing and Growth Capital
-
Qpex Biopharma Initiates Phase 1 Clinical Trial of QPX7728 for Drug-Resistant Bacterial Infections
-
CIT Invests in CySecure to Advance the Next Generation of Identity and Authentication Solutions
-
Strive Health Welcomes Brandi Riddle as Chief Financial Officer
-
BioInnovation Institute takes in new cohort of promising early-stage innovations
-
Metromile, a Leading Digital Insurance Platform, to Become Public Company via Merger with INSU Acquisition Corp. II (INAQ)
-
Metromile, a Leading Digital Insurance Platform, to Become Public Company

